Citalopram (Celexa): Uses, Side Effects and Withdrawal

Citalopram is a selective serotonin reuptake inhibitor, or SSRI. It is used for depression; NHS information also describes use for panic disorder. Celexa is a US brand. Approved indications and product instructions vary between countries. [1] [2]

Citalopram affects serotonin signaling. Benefit can take several weeks, so an early change in sleep or a side effect is not by itself a complete measure of the treatment response. [1]

Before a review, choose examples of what you hope will become easier: getting out of bed, managing work, or taking part in family life. Ask when progress will be assessed and what would lead your clinician to reconsider the plan.

It is commonly taken once daily. Follow the instructions for your exact tablets or liquid preparation; do not convert between formulations yourself. Do not double a missed dose. Your pharmacist can explain the product-specific instructions. [1]

Nausea, dry mouth, sweating, bowel changes, sleep disturbance and sexual difficulties can occur. Report persistent effects, including changes in sexual function, rather than assuming they must be tolerated. [1]

Describe both severity and practical impact. For example, say whether poor sleep prevents you from working or whether nausea affects eating. Ask what can be reviewed now and what information to collect before the next appointment.

Citalopram can affect the heart’s electrical rhythm. Tell your clinician about fainting, heart disease, a personal or family history of long QT syndrome, and medicines that affect rhythm. An ECG or blood tests may be appropriate. Fainting with palpitations, a seizure, severe allergic symptoms, or fever with confusion and muscle rigidity needs urgent medical assessment. [2]

New suicidal thoughts, severe agitation or unusually elevated mood need prompt assessment. Antidepressant warnings particularly emphasize younger people early in treatment or after dose changes. Use emergency services if you cannot stay safe. [2]

MAO inhibitors, other serotonergic medicines, drugs that prolong QT, blood thinners and some anti-inflammatory painkillers require particular checking. Do not add St John’s wort. Discuss seizures, bipolar symptoms, liver problems, pregnancy or breastfeeding before making changes. [1] [2]

Abrupt stopping can cause withdrawal, including dizziness, nausea, unusual sensations and sleep or mood changes. A prescriber should plan a gradual reduction suited to your experience. Do not use a fixed internet taper or switch directly to another antidepressant yourself. [2]

Ask for the plan in writing: what changes first, when to review, and whom to contact if you feel unwell. Explain any previous difficult interruption rather than treating it as an irrelevant detail.

A depression review should consider more than a change in sadness. Ask whether treatment is helping with interest, concentration, motivation and the daily activities that matter to you. In a panic-disorder plan, the discussion may concern recurrent attacks, fear of another attack and avoidance. Citalopram is used for depression and, in UK prescribing information, panic disorder; the licensed indication should be checked for the actual country and product. It is not an immediate rescue medicine for an individual panic attack. [1]

Agree how benefit will be assessed before deciding from a single good or bad day. For example, returning to a previously avoided journey may be a useful observation, while continued inability to work deserves attention even if another symptom improves. Medication and psychological treatment can address different parts of the plan. Asking what each is intended to do helps prevent a prescription from becoming the only measure of whether care is working.

The possibility of QT prolongation is a particular reason to give an accurate history of fainting, heart disease and other medication. QT is part of the electrical timing measured on an ECG. You do not need to interpret an ECG yourself; ask whether your history or medication combination calls for testing. Tell the prescriber about episodes of unexplained collapse and a family history of relevant rhythm disorders. [2]

A review should include nonpsychiatric prescriptions as well as antidepressants. Some medicines for heart rhythm and other conditions may change the risk assessment. Vomiting, poor intake or other illness can also matter to the wider clinical evaluation. Do not use a normal pulse reading from a watch as a substitute for professional advice. Fainting, a seizure or palpitations accompanied by significant illness warrants urgent medical assessment, particularly when symptoms are new. A history of panic does not prove that every racing heartbeat is another panic attack.

Citalopram may be part of treatment for a co-occurring depressive or anxiety disorder, but it is not a medication for acute alcohol detoxification, opioid-overdose reversal or the treatment of every substance use disorder. Mental health symptoms should be assessed alongside alcohol and drug use rather than automatically attributed to either medication or addiction. Ask the team to explain which problem citalopram is intended to treat and what separate treatment addresses the substance use. [1] SAMHSA medication-treatment overview.

Be specific about prescribed opioids, non-prescribed substances, sedatives and supplements. The pharmacist needs the actual combination, not only the medicines you consider psychiatric. During an admission or withdrawal episode, ask who is responsible for the antidepressant prescription and how new symptoms will be reviewed. Do not stop citalopram simply because a program is described as detox, and do not assume that taking it protects against dangerous alcohol or sedative withdrawal. A safe setting requires its own assessment.

Symptoms after reducing citalopram do not, by themselves, establish an addiction. Antidepressant withdrawal can occur after stopping, reducing or missing treatment. This is different from a pattern of compulsive drug use despite harm. The distinction matters because it avoids stigma and focuses the conversation on a tolerable medication change, ongoing care and assessment of symptoms. There is no need to describe prescribed antidepressant treatment as something that everyone must detox from. NICE guidance on medicines associated with withdrawal.

A planned reduction should be individualized and reviewed. A short schedule that suited another person may not suit your treatment duration, previous experience or available formulations. Ask how the plan can be changed if it becomes difficult and who will respond between appointments. Do not add a sedative, alcohol or another medicine to manage withdrawal on your own. That may introduce another risk and make the original problem harder to assess.

Dizziness or unusual sensations appearing after a medication change may raise a different question from a gradual return of a familiar depressive pattern. However, timing alone is not a diagnosis. NICE advises considering the onset, whether symptoms feel different from the original illness, and whether there are entirely new symptoms; clinical assessment may still be needed to rule out another cause. NICE discussion of withdrawal and recurrence.

Bring a simple timeline: the date a dose changed or was missed, when each symptom began, and what else changed around that time. Include illness, other prescriptions and substance use. You need not assign a cause before contacting your clinician. Ask what should prompt urgent care and which observations can be discussed at the next review. New suicidal thoughts, severe confusion or a serious physical reaction should never be treated as something to endure merely because a taper has begun.

Sexual difficulties, sweating, bowel symptoms or disrupted sleep can meaningfully affect whether treatment feels acceptable. These are appropriate subjects for a medication appointment. Describe what changed and when, including whether the concern was present before treatment. Do not assume a symptom must be tolerated indefinitely because it is listed as common, or that it must have been caused by citalopram simply because it appeared afterward. Your clinician can examine possible explanations. [1]

It may help to write a private question before the consultation. Ask how the issue can be assessed while protecting the benefit you have gained. Skipping tablets before intimacy or repeatedly changing the timing without advice is not a reliable solution and can complicate treatment. A useful plan acknowledges your preferences, sets a review point and avoids leaving you to choose between silent discomfort and an abrupt change.

Before travel, discharge or a change of prescriber, confirm the generic name, formulation, instructions and next supply. Citalopram and escitalopram are different medicines; a similar name is not authority to substitute one for the other. Ask a pharmacist about unfamiliar packaging rather than guessing from tablet appearance. Keep an up-to-date list that includes the intended indication and any monitoring requested. [2]

For a handover, record what has improved, which effects remain troublesome and whether a reduction is already in progress. Agree who will take responsibility for future decisions so that two services do not give conflicting instructions. Our depression treatment overview discusses a separate question: how care may be organized. Reading it does not mean that residential care, changing medication or stopping citalopram is necessarily appropriate.

Bring your current packet, the time you take it, and your actual pattern of use. Separate your questions into benefit, unwanted effects and practical concerns. Decide which question matters most before the appointment. The medication-review checklist offers a starting structure.

Is citalopram the same as escitalopram?

No. They are different medicines, despite similar names. Do not swap products or copy someone else’s prescription. [2]

Does a side effect mean treatment has failed?

Bring that question to your review with concrete examples. This page cannot decide whether a change is appropriate for you.

Does taking an antidepressant mean I need residential care?

No conclusion about the appropriate setting can be drawn from a medicine name alone. Treatment-setting questions require a separate assessment.

1. NHS: Citalopram.
2. MedlinePlus: Citalopram.

This summary is not an exhaustive interaction check or a substitute for your local medicine leaflet. See the medication library and editorial policy.